Cargando…
Teratoma maduro con diferenciación maligna tratado con peritonectomía con HIPEC
BACKGROUND: Mature teratomas belong to the group of germ line ovarian tumors; they generally have benign behavior. Malignant transformation occurs in 0.2% to 1% of tumors. The objective is to show the results of peritonectomy with HIPEC in the treatment of a mature teratoma with malignant differenti...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Mexicano del Seguro Social
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396065/ https://www.ncbi.nlm.nih.gov/pubmed/36542803 |
_version_ | 1785083722213621760 |
---|---|
author | Peña-Arriaga, Magaly Denise Ramírez-Salado, Diana Paola Ramírez-González, Laura Denisse Martínez-Gómez, Héctor Ruiz Esparza-Garrido, Ruth |
author_facet | Peña-Arriaga, Magaly Denise Ramírez-Salado, Diana Paola Ramírez-González, Laura Denisse Martínez-Gómez, Héctor Ruiz Esparza-Garrido, Ruth |
author_sort | Peña-Arriaga, Magaly Denise |
collection | PubMed |
description | BACKGROUND: Mature teratomas belong to the group of germ line ovarian tumors; they generally have benign behavior. Malignant transformation occurs in 0.2% to 1% of tumors. The objective is to show the results of peritonectomy with HIPEC in the treatment of a mature teratoma with malignant differentiation with signet ring cells. CLINICAL CASE: 43-year-old woman diagnosed with mature malignant teratoma with signet ring cells. It was performed optimal primary cytoreduction surgery, total hysterectomy, bilateral salpingo-oophorectomy, peritonectomy, appendectomy, cholecystectomy and splenectomy adding intraoperative hyperthermic chemotherapy (HIPEC). CONCLUSIONS: Malignant transformation of a mature teratoma of the ovary is a rare event, but not exceptional. HIPEC was used after optimal cytoreduction, with good results, since the patient is in a disease-free period of 36 months. It is necessary to report cases in order to compare different types of treatment to improve oncological results. |
format | Online Article Text |
id | pubmed-10396065 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Instituto Mexicano del Seguro Social |
record_format | MEDLINE/PubMed |
spelling | pubmed-103960652023-08-04 Teratoma maduro con diferenciación maligna tratado con peritonectomía con HIPEC Peña-Arriaga, Magaly Denise Ramírez-Salado, Diana Paola Ramírez-González, Laura Denisse Martínez-Gómez, Héctor Ruiz Esparza-Garrido, Ruth Rev Med Inst Mex Seguro Soc Casos Clínicos BACKGROUND: Mature teratomas belong to the group of germ line ovarian tumors; they generally have benign behavior. Malignant transformation occurs in 0.2% to 1% of tumors. The objective is to show the results of peritonectomy with HIPEC in the treatment of a mature teratoma with malignant differentiation with signet ring cells. CLINICAL CASE: 43-year-old woman diagnosed with mature malignant teratoma with signet ring cells. It was performed optimal primary cytoreduction surgery, total hysterectomy, bilateral salpingo-oophorectomy, peritonectomy, appendectomy, cholecystectomy and splenectomy adding intraoperative hyperthermic chemotherapy (HIPEC). CONCLUSIONS: Malignant transformation of a mature teratoma of the ovary is a rare event, but not exceptional. HIPEC was used after optimal cytoreduction, with good results, since the patient is in a disease-free period of 36 months. It is necessary to report cases in order to compare different types of treatment to improve oncological results. Instituto Mexicano del Seguro Social 2023 /pmc/articles/PMC10396065/ /pubmed/36542803 Text en © 2023 Revista Médica del Instituto Mexicano del Seguro Social. https://creativecommons.org/licenses/by-nc-nd/4.0/Esta obra está bajo una Licencia Creative Commons Atribución-NoComercial-SinDerivar 4.0 Internacional. |
spellingShingle | Casos Clínicos Peña-Arriaga, Magaly Denise Ramírez-Salado, Diana Paola Ramírez-González, Laura Denisse Martínez-Gómez, Héctor Ruiz Esparza-Garrido, Ruth Teratoma maduro con diferenciación maligna tratado con peritonectomía con HIPEC |
title | Teratoma maduro con diferenciación maligna tratado con peritonectomía con HIPEC |
title_full | Teratoma maduro con diferenciación maligna tratado con peritonectomía con HIPEC |
title_fullStr | Teratoma maduro con diferenciación maligna tratado con peritonectomía con HIPEC |
title_full_unstemmed | Teratoma maduro con diferenciación maligna tratado con peritonectomía con HIPEC |
title_short | Teratoma maduro con diferenciación maligna tratado con peritonectomía con HIPEC |
title_sort | teratoma maduro con diferenciación maligna tratado con peritonectomía con hipec |
topic | Casos Clínicos |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396065/ https://www.ncbi.nlm.nih.gov/pubmed/36542803 |
work_keys_str_mv | AT penaarriagamagalydenise teratomamadurocondiferenciacionmalignatratadoconperitonectomiaconhipec AT ramirezsaladodianapaola teratomamadurocondiferenciacionmalignatratadoconperitonectomiaconhipec AT ramirezgonzalezlauradenisse teratomamadurocondiferenciacionmalignatratadoconperitonectomiaconhipec AT martinezgomezhector teratomamadurocondiferenciacionmalignatratadoconperitonectomiaconhipec AT ruizesparzagarridoruth teratomamadurocondiferenciacionmalignatratadoconperitonectomiaconhipec |